Janus Henderson Group PLC Collegium Pharmaceutical, Inc Transaction History

Janus Henderson Group PLC

  • $182 Billion
  • Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 13,913 shares of COLL stock, worth $447,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,913
Previous 563,405 97.53%
Holding current value
$447,720
Previous $21.9 Million 97.96%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$31.36 - $39.99 $17.2 Million - $22 Million
-549,492 Reduced 97.53%
13,913 $447,000
Q1 2024

May 15, 2024
SELL
$31.23 - $40.91 $2 Million - $2.62 Million
-64,107 Reduced 10.22%
563,405 $21.9 Million
Q4 2023

Feb 14, 2024
SELL
$21.16 - $30.8 $5.35 Million - $7.78 Million
-252,686 Reduced 28.71%
627,512 $19.3 Million
Q3 2023

Nov 14, 2023
SELL
$21.23 - $24.28 $4.16 Million - $4.76 Million
-196,032 Reduced 18.21%
880,198 $19.7 Million
Q2 2023

Aug 14, 2023
SELL
$21.06 - $24.0 $4.26 Million - $4.85 Million
-202,124 Reduced 15.81%
1,076,230 $23.1 Million
Q1 2023

May 15, 2023
SELL
$23.0 - $29.88 $4.66 Million - $6.06 Million
-202,816 Reduced 13.69%
1,278,354 $30.7 Million
Q4 2022

Feb 14, 2023
SELL
$16.14 - $23.55 $7.02 Million - $10.2 Million
-434,828 Reduced 22.69%
1,481,170 $34.4 Million
Q3 2022

Nov 14, 2022
SELL
$15.46 - $20.1 $4.53 Million - $5.89 Million
-293,005 Reduced 13.26%
1,915,998 $30.7 Million
Q2 2022

Aug 15, 2022
SELL
$14.22 - $20.88 $2.1 Million - $3.09 Million
-147,779 Reduced 6.27%
2,209,003 $39.1 Million
Q1 2022

May 16, 2022
SELL
$17.2 - $22.5 $24.4 Million - $31.9 Million
-1,417,521 Reduced 37.56%
2,356,782 $48 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $5.68 Million - $6.93 Million
-324,608 Reduced 7.92%
3,774,303 $70.5 Million
Q3 2021

Nov 16, 2021
BUY
$17.75 - $25.39 $125,315 - $179,253
7,060 Added 0.17%
4,098,911 $80.9 Million
Q2 2021

Aug 16, 2021
BUY
$21.74 - $25.28 $329,882 - $383,598
15,174 Added 0.37%
4,091,851 $96.7 Million
Q1 2021

May 17, 2021
SELL
$19.25 - $26.1 $19.5 Million - $26.4 Million
-1,010,832 Reduced 19.87%
4,076,677 $96.6 Million
Q4 2020

Feb 16, 2021
SELL
$17.83 - $22.29 $621,375 - $776,806
-34,850 Reduced 0.68%
5,087,509 $102 Million
Q3 2020

Nov 16, 2020
SELL
$15.78 - $20.82 $222,908 - $294,103
-14,126 Reduced 0.28%
5,122,359 $107 Million
Q2 2020

Aug 14, 2020
BUY
$15.49 - $23.51 $503,719 - $764,521
32,519 Added 0.64%
5,136,485 $89.9 Million
Q1 2020

May 14, 2020
BUY
$13.89 - $25.45 $8.36 Million - $15.3 Million
601,617 Added 13.36%
5,103,966 $83.3 Million
Q4 2019

Feb 18, 2020
BUY
$10.7 - $22.24 $2.26 Million - $4.69 Million
210,843 Added 4.91%
4,502,349 $92.7 Million
Q3 2019

Nov 14, 2019
SELL
$10.16 - $13.28 $325,617 - $425,610
-32,049 Reduced 0.74%
4,291,506 $49.3 Million
Q2 2019

Jul 31, 2019
BUY
$10.62 - $16.59 $7.37 Million - $11.5 Million
693,812 Added 19.11%
4,323,555 $56.9 Million
Q1 2019

Apr 30, 2019
SELL
$13.58 - $18.72 $7.09 Million - $9.77 Million
-521,976 Reduced 12.57%
3,629,743 $55 Million
Q4 2018

Feb 06, 2019
BUY
$14.78 - $19.68 $471,422 - $627,713
31,896 Added 0.77%
4,151,719 $71.3 Million
Q3 2018

Nov 09, 2018
BUY
$14.16 - $24.3 $4.38 Million - $7.52 Million
309,477 Added 8.12%
4,119,823 $60.7 Million
Q2 2018

Aug 10, 2018
SELL
$21.79 - $28.29 $368,817 - $478,836
-16,926 Reduced 0.44%
3,810,346 $90.9 Million
Q1 2018

May 14, 2018
BUY
$18.15 - $29.21 $9.71 Million - $15.6 Million
535,214 Added 16.26%
3,827,272 $97.8 Million
Q4 2017

Feb 09, 2018
BUY
$9.3 - $19.14 $30.6 Million - $63 Million
3,292,058
3,292,058 $60.8 Million

Others Institutions Holding COLL

# of Institutions
253
Shares Held
40M
Call Options Held
84.2K
Put Options Held
19.6K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email